Clinical Trial Update: Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating stem cell mobilization with plerixafor in diabetic subjects compared with non-diabetic controls.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Mozobil (plerixafor)

Snippet

Sponsor: University of Padova | Conditions: Diabetes | Phase 4 | Status: COMPLETED